Top Markets
Coin of the day
Senores Pharmaceuticals Ltd. Senores Pharmaceuticals Ltd.

Senores Pharmaceuticals Ltd.

SENORES
Rang in Aktien #11030
Established in 2017 and headquartered in Ahmedabad, India, Senores... Established in 2017 and headquartered in Ahmedabad, India, Senores Pharmaceuticals Ltd. is actively involved in the development, manufacturing, and global commercialization of pharmaceutical and related products. Its extensive portfolio reaches markets across India, the United States, the United Kingdom, Canada, and other international territories. The company specializes in a diverse array of therapeutic solutions, encompassing analgesics/antipyretics, anesthetics, antibacterials, antivirals, antifungals, antioxidants, antineoplastics, blood-related therapies, cardiovascular and neurological medications, antacids, and vitamin and mineral supplements. Additionally, Senores offers a selection of generic drugs targeting pain, inflammation, fever, diabetes, malaria, and urinary tract conditions, as well as neutral supplements. Complementing its product offerings, the firm also provides management and consultancy services.
Aktienkurs
$16.36
Zuletzt synchronisiert: 2026-08-28
Marktkapitalisierung
$753.27M
Veränderung (1 Tag)
0.51%
Veränderung (1 Jahr)
108.95%
Land
IN
Handel Senores Pharmaceuticals Ltd. (SENORES)

Kategorie

Dividendenhistorie für Senores Pharmaceuticals Ltd. (SENORES)
Senores Pharmaceuticals Ltd. (Aktienkürzel: SENORES) zahlte insgesamt 0 Dividenden.
Die Summe aller Dividenden (angepasst an Aktiensplits) beträgt: 0.00
Dividendenrendite (TTM): 0
Dividendenzahlungen für Senores Pharmaceuticals Ltd. (SENORES) von 2026 bis 2026
Jährliche Dividendenzahlungen
Jahr Dividende (angepasst an Aktiensplits) ändert
Nicht genügend Daten für die angegebenen Daten.
Liste aller Dividendenzahlungen
Jahr Dividende ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenzahlungen ähnlicher Unternehmen oder Wettbewerber
Unternehmen Anzahl der Dividendenzahlungen Land
215.00%
US
225.00%
US
53.00%
US
33.00%
CH
223.00%
US